drugset / Trial / NCT00487682
Dose-finding Study of ASP2151 in Subjects With Herpes Zoster
RandomizedParallel-groupQuadruple-blindTreatment
Summary
To investigate the efficacy and safety of three different doses of ASP2151, as compared to valacyclovir hydrochloride in subjects with herpes zoster, and to determine the recommended clinical dose.
Timeline
- Start
- 2007-11-13
- Primary completion
- 2008-09-01
- Completion
- 2008-09-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Amenamevir | Small molecule | — | Oral |
| Comparator | Valacyclovir | Unknown | — | Oral |